Fair question.
"A 36-year-old woman with rheumatoid arthritis died in July, while participating in a gene-therapy clinical trial. Some experts say she shouldn't have received such an unpredictable, potentially dangerous treatment in the first place."
Just like what they want to do to fat people.
"The tragedy highlights the ethics of testing risky therapies on patients whose ailments are not life-threatening and are controlled by other means."
Like being a fat person where the absolute cure is, and will always be, fewer Calories in than out.
Posts
1 comment:
Death would be an acceptable risk for people suffering from illness with rather short life expectancy- with death being imminent they can participate in the study and hopfully get lucky, or, not make it, but contribute to advancement in medicine.
In the case of rheumatoid arthitis , she could have lived with the symptoms of the disease controlled by pain killers and other medications. It looks like in this case the risks did outweight the benefits and she should not have been offered to make this kind of choice when consenting to participate in the trial.
With obesity, in my opinion , the majority of people could be subject to any risky therapy ONLY after a serious effort to control how much they eat and sweating out a lot.
Kida Tommy
Post a Comment